Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heterologous Effects of DTP and Influenza Vaccination
NCT02765126Unknown
- Sponsor
- Clifford Craig Foundation
- Start
- May 2016
- Primary completion
- Dec 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of diphtheria + tetanus + acellular pertussis vaccine in diphtheria, Tetanus and pertussis (3 arms), sponsored by Clifford Craig Foundation. Primary endpoint: Number of inflammation reactive TNFR2+ regulatory T cells at 26 weeks. Status: unknown.
02
Drugs
diphtheria + tetanus + acellular pertussis vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT02765126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02765126.